On July 18, 2023, David C. Benedicto, principal accounting officer of Adamis Pharmaceuticals Corporation (Company), notified the company that he was tendering his resignation from the company effective July 21, 2023. The Company will commence a search for a new chief financial officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0293 USD | -2.33% | -7.28% | -95.82% |
May. 30 | First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation | CI |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
1st Jan change | Capi. | |
---|---|---|
-95.82% | 303K | |
+47.07% | 765B | |
-6.76% | 354B | |
+19.01% | 331B | |
+8.77% | 299B | |
+18.87% | 248B | |
-2.09% | 219B | |
+10.86% | 216B | |
+4.97% | 164B | |
-2.78% | 162B |
- Stock Market
- Equities
- DMKPQ Stock
- News DMK Pharmaceuticals Corporation
- Adamis Pharmaceuticals Corporation Announces Resignation of David C. Benedicto as Principal Accounting Officer